H
Hugo F. Londero
Researcher at Fundación Favaloro
Publications - 26
Citations - 744
Hugo F. Londero is an academic researcher from Fundación Favaloro. The author has contributed to research in topics: Stent & Carotid stenting. The author has an hindex of 7, co-authored 26 publications receiving 728 citations.
Papers
More filters
Journal ArticleDOI
Global experience in cervical carotid artery stent placement
Michael H. Wholey,Mark H. Wholey,Klaus Mathias,Gary S. Roubin,Edward B. Diethrich,Michel Henry,Steven R. Bailey,Patrice Bergeron,Gerald Dorros,Eles G,P Gaines,Camilo R. Gomez,Bruce H. Gray,J Guimaraens,Randall T. Higashida,D S Ho,Barry T. Katzen,A Kambara,Vijay Kumar,Jean Claude Laborde,Martin B. Leon,Lim Mc,Hugo F. Londero,Juan E. Mesa,A Musacchio,Subbarao Myla,S. R. Ramee,A Rodriquez,Kenneth Rosenfield,N Sakai,Fayaz A. Shawl,Horst Sievert,George P. Teitelbaum,Jacques Theron,P Vaclav,Vozzi C,Jay S. Yadav,S I Yoshimura +37 more
TL;DR: The periprocedure risks for major and minor strokes and death are generally acceptable at this early stage of development and have not changed significantly since the first survey results.
Journal Article
PTA and Stents in the Treatment of Extracranial Circulation.
Journal ArticleDOI
Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation.
Eberhard Grube,Antonio Colombo,Eugen Hauptmann,Hugo F. Londero,Nicolaus Reifart,Ulrich Gerckens,Gregg W. Stone +6 more
TL;DR: Distal cerebral protection with the FilterWire during carotid stenting is feasible and safe, results in capture and extraction of atheroembolic debris in the majority of patients while affording uninterrupted cerebral perfusion, and in this initial multicenter experience was associated with a high rate of procedural success without major complications.
Journal ArticleDOI
Initial experience with transradial access for carotid artery stenting.
TL;DR: Carotid artery stenting using TRA was safe and technically feasible, and there were no deaths, myocardial infarction, or radial access site complications.
Journal ArticleDOI
Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial.
TL;DR: This study demonstrated the ABPS S ESAME Stent™ has excellent acute success, low 30 day MACE rates and 9 month patency of the SESAME is similar to balloon expandable stents without embolic protection.